Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Legrand

Showing results (1-10 of 309) with videos related to

Pageof 31
Sort By:
British Journal of Anaesthesia|January 6, 2026
Hydroxocobalamin for vasoplegia in cardiac surgery: an uncertain balance of risk and benefit. Comment on Br J Anesth 2025; 135: 870-7Matthieu Legrand
The Lancet. Respiratory Medicine|October 11, 2018
Negative trials in critical care medicine and the hurdlesMatthieu Legrand
Kidney International Reports|January 1, 2019
Hydroxocobalamin as a Cause of Oxalate NephropathyMatthieu Legrand
British Journal of Anaesthesia|April 20, 2024
Should renin-angiotensin system inhibitors be held prior to major surgery?Matthieu Legrand
Journal of Thoracic Disease|November 22, 2016
Should we apply "early" initiation of renal replacement therapy to critically ill patients with acute kidney injury?Matthieu Legrand
JAMA Cardiology|November 18, 2020
Complications in Patients With COVID-19Matthieu Legrand
Journal of Intensive Medicine|January 28, 2025
New drugs for acute kidney injuryGeoffroy Hariri, Matthieu Legrand
British Journal of Anaesthesia|January 28, 2025
Management of renin-angiotensin system inhibitors prior to major surgery: insights from the STOP-or-NOT trialMatthieu Legrand, Etienne Gayat
Revue De L'Infirmiere|December 25, 2019
Hugues Lefort, Matthieu Legrand
Critical Care Medicine|December 1, 2020
Angiotensin-Converting Enzyme Inhibitors and or Receptor Blockers After Acute Kidney Injury: Rehabilitation of the SupervillainsMatthieu Legrand, Kathleen Liu
Pageof 31

Showing results (1-10 of 309) with videos related to

Sort By:
Pageof 31
British Journal of Anaesthesia|January 6, 2026
Hydroxocobalamin for vasoplegia in cardiac surgery: an uncertain balance of risk and benefit. Comment on Br J Anesth 2025; 135: 870-7Matthieu Legrand
The Lancet. Respiratory Medicine|October 11, 2018
Negative trials in critical care medicine and the hurdlesMatthieu Legrand
Kidney International Reports|January 1, 2019
Hydroxocobalamin as a Cause of Oxalate NephropathyMatthieu Legrand
British Journal of Anaesthesia|April 20, 2024
Should renin-angiotensin system inhibitors be held prior to major surgery?Matthieu Legrand
Journal of Thoracic Disease|November 22, 2016
Should we apply "early" initiation of renal replacement therapy to critically ill patients with acute kidney injury?Matthieu Legrand
JAMA Cardiology|November 18, 2020
Complications in Patients With COVID-19Matthieu Legrand
Journal of Intensive Medicine|January 28, 2025
New drugs for acute kidney injuryGeoffroy Hariri, Matthieu Legrand
British Journal of Anaesthesia|January 28, 2025
Management of renin-angiotensin system inhibitors prior to major surgery: insights from the STOP-or-NOT trialMatthieu Legrand, Etienne Gayat
Revue De L'Infirmiere|December 25, 2019
Hugues Lefort, Matthieu Legrand
Critical Care Medicine|December 1, 2020
Angiotensin-Converting Enzyme Inhibitors and or Receptor Blockers After Acute Kidney Injury: Rehabilitation of the SupervillainsMatthieu Legrand, Kathleen Liu
Pageof 31